Description
|
This study is part of a multi-country research project that utilizes standardized methods to generate cost evidence on the delivery of COVID-19 (C19) vaccines in Vietnam, Bangladesh, and the Philippines in Asia, and Mozambique, Côte d’Ivoire, the Democratic Republic of the Congo, and Uganda in Africa. This was a retrospective, bottom-up costing study that estimated the financial and economic costs of delivering C19 vaccines in the DRC through routine and campaign delivery. The study estimates delivery costs for routine vaccine delivery and campaigns, covering different periods during which sites were active between November 2021 and June 2022. The study was conducted from the payer perspective, including costs incurred by health service providers, the immunization program at the Ministry of Public Health, Hygiene and Prevention, and development partners, at all levels of the health system. Data was collected retrospectively at a sample of 26 health facilities in the provinces of Kinshasa, Haut-Katanga, and Kongo Central, as well as all relevant health zone, provincial, national level offices, and 4 development partner organizations. Costs were disaggregated across program activities and resource types to analyze cost drivers. Volume-weighted average unit costs were estimated for each administrative level and then aggregated to obtain the overall volume-weighted cost per dose. (2024-04-09)
|